Gemeprost
- Level
- Commodity
- Parent
- 51413300
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51413302This classification denotes a prostaglandin analogue, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 45KZB1FOLS. European Medicines Agency schedules Gemeprost in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07893MIG. Gemeprost generally arises in the molecular formula C23H38O5. The term GEMEPROST is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 34, no. 10 1980, list 20.) GEMEPROST is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gemeprost under HS 29375000 and SITC 54156. As of Q4 2014, GEMEPROST remains the US FDA Preferred Term for this commodity. Gemeprost bears US NLM identifiers UMLS ID C0044923 and NCI Concept Code C87382. SMILES: OC1C(C(CCCC/C=C/C(=O)OC)C(=O)C1)/C=C/C(O)C(CCCC)(C)C.
Same parent
Under 51413300 · 3Activities that produce or sell this
KBLI · 8Inherited from family 51410000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.